|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
11/13/2012
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
-1,489
|
$146.60
|
-1.56%
|
|
11/13/2012
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
-200
|
$144.36
|
-0.21%
|
|
11/13/2012
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
-1,400
|
$146.58
|
-1.50%
|
|
11/13/2012
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
-300
|
$145.65
|
-0.32%
|
|
11/13/2012
|
SING GEORGE L
|
Director
|
-5,000
|
$148.00
|
-3.63%
|
|
11/8/2012
|
Powchik Peter
|
SVP Clinical Development & Reg
|
-900
|
$139.05
|
-5.66%
|
|
11/8/2012
|
Powchik Peter
|
SVP Clinical Development & Reg
|
-14,244
|
$138.59
|
-47.27%
|
|
11/1/2012
|
RYAN ARTHUR F
|
Director
|
-10,000
|
$145.57
|
-19.86%
|
|
10/26/2012
|
BROWN MICHAEL S
|
Director
|
3,000
|
$23.84
|
20.46%
|
|
10/26/2012
|
BROWN MICHAEL S
|
Director
|
-3,000
|
$154.69
|
-16.99%
|
|
10/25/2012
|
Van Plew Daniel P
|
SVP & General Mgr Industrial O
|
-11,922
|
$159.55
|
-33.63%
|
|
10/25/2012
|
Van Plew Daniel P
|
SVP & General Mgr Industrial O
|
30,000
|
$21.92
|
313.55%
|
|
10/25/2012
|
BROWN MICHAEL S
|
Director
|
-2,000
|
$155.34
|
-12.00%
|
|
10/25/2012
|
BROWN MICHAEL S
|
Director
|
2,000
|
$23.84
|
13.64%
|
|
10/25/2012
|
Van Plew Daniel P
|
SVP & General Mgr Industrial O
|
-4,121
|
$159.55
|
-10.41%
|
|
9/19/2012
|
Powchik Peter
|
SVP Clinical Development & Reg
|
-1,000
|
$148.00
|
-3.21%
|
|
9/19/2012
|
Powchik Peter
|
SVP Clinical Development & Reg
|
-3,200
|
$147.16
|
-9.32%
|
|
9/19/2012
|
Powchik Peter
|
SVP Clinical Development & Reg
|
-2,977
|
$146.89
|
-7.98%
|
|
9/18/2012
|
Powchik Peter
|
SVP Clinical Development & Reg
|
-6,130
|
$148.78
|
-14.11%
|
|
9/18/2012
|
Powchik Peter
|
SVP Clinical Development & Reg
|
15,000
|
$16.80
|
49.78%
|
|
9/18/2012
|
Powchik Peter
|
SVP Clinical Development & Reg
|
-1,693
|
$148.78
|
-3.75%
|
|
9/6/2012
|
BAKER CHARLES A
|
Director
|
13,714
|
$15.01
|
143.00%
|
|
9/6/2012
|
BAKER CHARLES A
|
Director
|
-13,714
|
$150.00
|
-58.85%
|
|
9/5/2012
|
BAKER CHARLES A
|
Director
|
1,286
|
$15.01
|
13.41%
|
|
9/5/2012
|
BAKER CHARLES A
|
Director
|
-1,286
|
$150.00
|
-11.82%
|
|
8/31/2012
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
-503
|
$144.59
|
-0.52%
|
|
8/31/2012
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
-2,691
|
$145.60
|
-2.82%
|
|
8/31/2012
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
-1,626
|
$146.37
|
-1.76%
|
|
8/31/2012
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
-476
|
$147.21
|
-0.52%
|
|
8/29/2012
|
STAHL NEIL
|
SVP Research and Development S
|
-9,386
|
$145.44
|
-12.60%
|
|
8/29/2012
|
STAHL NEIL
|
SVP Research and Development S
|
-5,998
|
$146.41
|
-9.21%
|
|
8/29/2012
|
STAHL NEIL
|
SVP Research and Development S
|
-1,500
|
$144.92
|
-1.97%
|
|
8/28/2012
|
STAHL NEIL
|
SVP Research and Development S
|
40,000
|
$21.92
|
67.66%
|
|
8/28/2012
|
STAHL NEIL
|
SVP Research and Development S
|
-6,017
|
$145.70
|
-6.07%
|
|
8/28/2012
|
STAHL NEIL
|
SVP Research and Development S
|
-17,099
|
$145.70
|
-18.37%
|
|
8/27/2012
|
McCorkle Douglas S
|
VP Controller & Asst Treasurer
|
-256
|
$145.23
|
-6.00%
|
|
8/24/2012
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
-2,149
|
$145.22
|
-91.49%
|
|
8/24/2012
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
-4,178
|
$144.67
|
-64.01%
|
|
8/24/2012
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
-200
|
$142.71
|
-2.97%
|
|
8/24/2012
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
-200
|
$146.07
|
-100.00%
|
|
8/23/2012
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
-3,623
|
$141.85
|
-35.00%
|
|
8/23/2012
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
-1,385
|
$141.85
|
-11.80%
|
|
8/23/2012
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
9,250
|
$21.25
|
372.23%
|
|
8/23/2012
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
-1,268
|
$141.85
|
-21.58%
|
|
8/23/2012
|
McCorkle Douglas S
|
VP Controller and Asst Treasur
|
-2,122
|
$141.85
|
-46.06%
|
|
8/23/2012
|
ROBERTS WILLIAM
|
VP Regulatory Development and
|
-15,000
|
$144.00
|
-24.53%
|
|
8/23/2012
|
SING GEORGE L
|
Director
|
-5,000
|
$142.00
|
-3.50%
|
|
8/23/2012
|
SING GEORGE L
|
Director
|
5,000
|
$18.80
|
3.63%
|
|
8/22/2012
|
SING GEORGE L
|
Director
|
5,000
|
$18.80
|
3.63%
|
|
8/22/2012
|
SING GEORGE L
|
Director
|
-5,000
|
$139.00
|
-3.50%
|
|
8/10/2012
|
RYAN ARTHUR F
|
Director
|
-10,000
|
$136.15
|
-14.85%
|
|
8/7/2012
|
GILMAN ALFRED G
|
Director
|
-15,000
|
$139.56
|
-100.00%
|
|
8/6/2012
|
BROWN MICHAEL S
|
Director
|
3,000
|
$23.84
|
20.46%
|
|
8/6/2012
|
BROWN MICHAEL S
|
Director
|
-3,000
|
$136.29
|
-16.99%
|
|
8/1/2012
|
Powchik Peter
|
SVP Clinical Development & Reg
|
4,562
|
$21.92
|
30.12%
|
|
8/1/2012
|
Powchik Peter
|
SVP Clinical Development & Reg
|
10,428
|
$15.64
|
52.92%
|
|
7/30/2012
|
Terifay Robert J
|
SVP Commercial
|
-14,833
|
$135.49
|
-44.76%
|
|
7/30/2012
|
Terifay Robert J
|
SVP Commercial
|
-67
|
$134.99
|
-0.20%
|
|
7/30/2012
|
Terifay Robert J
|
SVP Commercial
|
-6,600
|
$136.26
|
-36.05%
|
|
7/30/2012
|
Terifay Robert J
|
SVP Commercial
|
-2,334
|
$137.58
|
-19.94%
|
|
7/27/2012
|
Terifay Robert J
|
SVP Commercial
|
-1,994
|
$137.39
|
-4.98%
|
|
7/27/2012
|
Terifay Robert J
|
SVP Commercial
|
-4,839
|
$137.39
|
-12.72%
|
|
7/27/2012
|
Terifay Robert J
|
SVP Commercial
|
14,000
|
$16.80
|
149.38%
|
|
7/27/2012
|
Terifay Robert J
|
SVP Commercial
|
12,500
|
$21.92
|
45.39%
|
|
7/27/2012
|
Terifay Robert J
|
SVP Commercial
|
-9,856
|
$137.39
|
-26.36%
|
|
7/27/2012
|
Terifay Robert J
|
SVP Commercial
|
-2,980
|
$137.39
|
-7.38%
|
|
7/27/2012
|
Terifay Robert J
|
SVP Commercial
|
24,375
|
$16.80
|
152.34%
|
|
7/27/2012
|
Terifay Robert J
|
SVP Commercial
|
-1,711
|
$137.39
|
-7.32%
|
|
7/27/2012
|
Terifay Robert J
|
SVP Commercial
|
-5,661
|
$137.39
|
-26.13%
|
|
7/26/2012
|
SING GEORGE L
|
Director
|
5,000
|
$18.80
|
3.63%
|
|
7/26/2012
|
Powchik Peter
|
SVP Clinical Development & Reg
|
-4,519
|
$130.40
|
-20.39%
|
|
7/26/2012
|
SING GEORGE L
|
Director
|
-5,000
|
$135.00
|
-3.50%
|
|
7/26/2012
|
Powchik Peter
|
SVP Clinical Development & Reg
|
-2,500
|
$131.07
|
-14.17%
|
|
7/25/2012
|
Powchik Peter
|
SVP Clinical Development & Reg
|
-5,994
|
$126.76
|
-21.29%
|
|
7/25/2012
|
Powchik Peter
|
SVP Clinical Development & Reg
|
15,000
|
$16.80
|
99.05%
|
|
7/25/2012
|
Powchik Peter
|
SVP Clinical Development & Reg
|
-1,987
|
$126.76
|
-6.59%
|
|
6/19/2012
|
STAHL NEIL
|
SVP Res & Dev Sciences
|
-24,848
|
$115.60
|
-25.35%
|
|
6/19/2012
|
STAHL NEIL
|
SVP Res & Dev Sciences
|
-9,080
|
$116.41
|
-12.41%
|
|
6/19/2012
|
STAHL NEIL
|
SVP Res & Dev Sciences
|
-4,383
|
$117.34
|
-6.84%
|
|
6/19/2012
|
STAHL NEIL
|
SVP Res & Dev Sciences
|
-600
|
$118.10
|
-1.00%
|
|
6/18/2012
|
STAHL NEIL
|
SVP Res & Dev Sciences
|
-39,411
|
$115.29
|
-28.67%
|
|
6/18/2012
|
STAHL NEIL
|
SVP Res & Dev Sciences
|
95,079
|
$20.32
|
160.82%
|
|
6/18/2012
|
STAHL NEIL
|
SVP Res & Dev Sciences
|
-16,757
|
$115.29
|
-10.87%
|
|
5/31/2012
|
SING GEORGE L
|
Director
|
-3,300
|
$134.74
|
-2.31%
|
|
5/31/2012
|
SING GEORGE L
|
Director
|
-1,700
|
$135.15
|
-1.22%
|
|
5/30/2012
|
SING GEORGE L
|
Director
|
-5,000
|
$134.00
|
-3.38%
|
|
5/24/2012
|
Aberman Michael S
|
VP Strategy and Investor Relat
|
500
|
$24.00
|
5.00%
|
|
5/21/2012
|
SHOOTER ERIC M
|
Director
|
-10,000
|
$124.07
|
-100.00%
|
|
5/21/2012
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
4,562
|
$21.92
|
5.69%
|
|
5/21/2012
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
11,682
|
$11.64
|
13.79%
|
|
5/21/2012
|
SHOOTER ERIC M
|
Director
|
-8,000
|
$123.23
|
-100.00%
|
|
5/18/2012
|
SHOOTER ERIC M
|
Director
|
-2,000
|
$124.04
|
-100.00%
|
|
5/3/2012
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
-700
|
$137.19
|
-0.86%
|
|
5/3/2012
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
-5,872
|
$133.51
|
-5.61%
|
|
5/3/2012
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
-6,265
|
$135.60
|
-6.85%
|
|
5/3/2012
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
-7,294
|
$134.47
|
-7.39%
|
|
5/3/2012
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
-4,211
|
$136.34
|
-4.94%
|
|
5/3/2012
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
-100
|
$138.48
|
-0.12%
|
|
5/3/2012
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
-200
|
$132.96
|
-0.19%
|
|
5/2/2012
|
GOLDBERG MURRAY A
|
SVP Finance and Admin CFO Trea
|
-4,661
|
$136.37
|
-3.86%
|